Peter Laurence Molloy
Fortune : 968 733 $ au 31/05/2026
Fortune : 968 733 $ au 31/05/2026
Dr. Peter L.
Molloy is an Executive Chairman & Chief Executive Officer at Firebrick Pharma Ltd. He is on the Board of Directors at Innovation Angel Foundation, Inc. Dr. Molloy was previously employed as an Independent Non-Executive Director by Parnell Pharmaceuticals Holdings Ltd., an Independent Non-Executive Director by Viralytics Pty Ltd., a Chief Executive Officer & Managing Director by Biota Holdings Ltd., a President & Chief Executive Officer by SLIL Biomedical Corp, a Chief Executive Officer & Managing Director by Calgene Pacific Ltd., a President by Moleculon, Inc., a Managing Director by Pfizer (Perth) Pty Ltd., a Vice President-Strategic Marketing by Pharmacia Corp., and a President & Chief Executive Officer by SYNkinase USA, Inc. He also served on the board at Race Oncology Ltd. He received his undergraduate degree from the University of Melbourne and an MBA from the University of Adelaide.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FIREBRICK PHARMA LIMITED 11,25% | 20/05/2026 | 32 056 017 ( 11,25% ) | 968 733 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FIREBRICK PHARMA LIMITED | Directeur Général | 12/04/2012 |
Innovation Angel Foundation, Inc. | Directeur/Membre du Conseil | 01/10/2011 |
| Sociétés | Poste | Fin |
|---|---|---|
| RACURA ONCOLOGY LTD | Directeur Général | 20/05/2020 |
| PARL PHAR | Directeur/Membre du Conseil | 08/09/2014 |
| VIRALYTICS LTD. | Directeur/Membre du Conseil | 01/09/2014 |
| BIOTA HOLDINGS LTD. | Directeur Général | 09/12/2005 |
SLIL Biomedical Corp
SLIL Biomedical Corp Miscellaneous Commercial ServicesCommercial Services Researches, discovers, and develops drugs to treat cancer and other diseases | Directeur Général | 01/06/2002 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 14 |
|---|---|
Moleculon, Inc.
Moleculon, Inc. Pharmaceuticals: GenericHealth Technology Manufactures and supplies generic drug products | Health Technology |
Biota Holdings Pty Ltd.
Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
Viralytics Pty Ltd.
Viralytics Pty Ltd. BiotechnologyHealth Technology Researches and develops anti-cancer drugs | Health Technology |
University of Adelaide
University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Florigene Ltd.
Florigene Ltd. BiotechnologyHealth Technology Provides genetic modification technology to bridge genetic gaps and deliver improvements to flower species | Health Technology |
SLIL Biomedical Corp
SLIL Biomedical Corp Miscellaneous Commercial ServicesCommercial Services Researches, discovers, and develops drugs to treat cancer and other diseases | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Pfizer (Perth) Pty Ltd.
Pfizer (Perth) Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Synkinase USA, Inc.
Synkinase USA, Inc. BiotechnologyHealth Technology Provides molecule drug discovery services | Health Technology |
Parnell Pharmaceuticals Holdings Ltd.
Parnell Pharmaceuticals Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company that develops, manufactures and markets animal pharmaceutical products | Health Technology |
Firebrick Pharma Ltd.
Firebrick Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Innovation Angel Foundation, Inc. | |
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national